CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-28 | Benaim Ely Chief Medical Officer | Exercise or conversion | +2,375 | 4,750 | ||
| 2019-02-28 | Benaim Ely Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −2,375 | 4,750 | ||
| 2019-01-25 | Benaim Ely Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-03-07 | Benaim Ely Chief Medical Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2018-02-28 | Benaim Ely Chief Medical Officer | Exercise or conversion | +2,375 | 2,375 | ||
| 2018-02-28 | Benaim Ely Chief Medical Officer | Exercise or conversion · Restricted Stock Units | +2,375 | 7,125 | ||
| 2018-01-26 | Benaim Ely Chief Medical Officer | Grant or award · Stock Option (right to buy) | +45,443 | 45,443 | ||
| 2017-01-20 | Benaim Ely Chief Medical Officer | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2017-01-20 | Benaim Ely Chief Medical Officer | Grant or award · Restricted Stock Units | +95,000 | 95,000 | ||
| 2016-01-28 | Benaim Ely Chief Medical Officer | Grant or award · Stock Option (right to buy) | +98,734 | 98,734 | ||
| 2016-01-28 | Benaim Ely Chief Medical Officer | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2015-02-02 | Benaim Ely Chief Medical Officer | Grant or award · Stock Option (right to buy) | +1,200,000 | 1,200,000 |
Page 1 of 1 · 12 trades